Ocean Biomedical, Inc. [Rocket]

Overview

Ocean Biomedical, Inc.

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
10/12/2023	8-K	Quarterly results
10/06/2023	4	KATHURIA CHIRINJEEV (10% Owner) has filed a Form 4 on Ocean Biomedical, Inc.
10/06/2023	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
10/02/2023	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
08/16/2023	424B3	Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/16/2023	424B3	Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/14/2023	10-Q	Quarterly Report for the period ended June 30, 2023

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21
Revenues	0.0	0.0
Cost of goods sold	0.0	0.0
Gross profit	0.0	0.0
Research and development	8.4	33.9
General and administrative	7.7	28.4
EBIT	-16.1	-62.3
Pre-tax income	-17.4	-62.3
Income taxes	0.0	0.0
Tax rate	0.0%	0.0%
Net income	-17.4	-62.3

Diluted EPS	($0.74)	($2.67)
Shares outstanding (diluted)	23.4	23.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy